www.fdanews.com/articles/167423-scenihr-recommends-phased-approach-to-risk-evaluation-of-nanomaterials
SCENIHR Recommends Phased Approach to Risk Evaluation of Nanomaterials
September 26, 2014
Manufacturers of medical devices that contain nanomaterials should use a phased approach to evaluate risk to avoid unnecessary testing, an expert committee of the European Commission recommends.
International Medical Device Regulatory Monitor